Moderna Inc. has agreed to pay $950 million to resolve a lawsuit related to its COVID-19 vaccine delivery technology, eliminating an imminent financial risk for the vaccine maker. Moderna has reached a global settlement with Arbutus Biopharma and Genevant Sciences GmbH regarding existing and future vaccine-related matters, with no further royalty payments required in the future.
